Global clinical trials activity decreases 2.9% in Q2 2020

ACRO releases report on risk-based framework approach within decentralised trials

Activities of clinical studies have been traditionally cantered around trial sites where participants travel for...

Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials

After announcing a partnership to assess the safety of potential Covid-19 drugs, TRHC and Regence...

A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment

Having grown into one of the biggest companies in the biotech sphere since its inception...

FibroGen: The company attempting to treat pneumonia in Covid-19 patients

FibroGen recently announced enrolment of patients in a clinical study of its antibody drug pamrevlumab...

Moderna timeline: How the biotech firm has moved alongside pharma giants in Covid-19 vaccine race

Alongside Pfizer, Merck, Johnson & Johnson and AstraZeneca, Moderna was recently selected as a Covid-19...

How the University of Oxford is leading the Covid-19 fight on multiple fronts

As well as developing its own Covid-19 vaccine, the University of Oxford is leading multiple...

Majority of Covid-19 clinical trials showing ‘encouraging’ signs, says analyst

Remdesivir — a drug originally developed to treat hepatitis C — is the most prominent...

UCI Health to initiate drug clinical trial to treat Covid-19 patients

UCI Health will initiate a clinical study of a drug to treat patients critically ill...

TriNetX to add Brazil’s real-world dataset to its network

Health research network TriNetX has partnered with real-world evidence (RWE) data provider Techtrials to add...